Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study

被引：0
|
作者：
Vazquez, S. [1 ]
Leon, L. [2 ]
Gracia, J. M. [3 ]
Casal, J. [4 ]
Lazaro, M. [5 ]
Firvida, J. L. [6 ]
Amenedo, M. [7 ]
Santome, L. [8 ]
Cardona, J. V. [9 ]
Macia, S. [10 ]
机构：
[1] Complexo Hosp Xeral Calde, Lugo, Spain
[2] Complexo Hosp Univ Santiago, Santiago De Compostela, Spain
[3] Hosp Cabuenes, Gijon, Spain
[4] Complexo Hosp Univ Vigo Hosp Do Meixoeiro, Vigo, Spain
[5] Complexo Hosp Univ Vigo Hosp Xeral Cies, Vigo, Spain
[6] Complexo Hosp Ourense, Orense, Spain
[7] Ctr Oncol Galicia, La Coruna, Spain
[8] Hosp POVISA, Vigo, Spain
[9] Roche Farma SA, Madrid, Spain
[10] Hosp Gen Elda, Elda, Spain
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71858-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：548 / 549
页数：2
相关论文
共 50 条
  • [1] A GALICIAN LUNG CANCER GROUP PHASE II STUDY OF BEVACIZUMAB (B), CISPLATIN AND VINORELBINE IN CHEMO-NAIVE PATIENTS (P) WITH NON SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC)
    Areses Manrique, M. C.
    Vazquez Estevez, S.
    Gracia, J. M.
    Casal Rubio, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    Santome, L.
    Macia, S.
    Leon, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 145 - 145
  • [2] Bevacizumab (B), Cisplatin and Vinorelbine in Chemo-Naive Patients (P) with Non Squamous Non Small Cell Lung Cancer (NSCLC): A Galician Lung Cancer Group Phase II study
    Vazquez, Sergio
    Leon, Luis
    Gracia, Jose M.
    Casal, Joaquin
    Lazaro, Martin
    Luis Firvida, Jose
    Amenedo, Margarita
    Santome, Lucia
    Macia, Sonia
    Alvarez, Elena
    Vicente Cardona, Jose
    Vazquez, Francisca
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S718 - S719
  • [3] A Galician Lung Cancer Group phase II study of bevacizumab (B), cisplatin, and vinorelbine in chemotherapy-naive patients (p) with non-squamous non-small cell lung cancer (NSCLC)
    Leon, L.
    Vazquez, S.
    Gracia, J.
    Casal, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    santome, L.
    Cardona, J. V.
    Macia, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Bevacizumab (B), cisplatin, and vinorelbine in chemotherapy-naive patients (p) with nonsquamous non-small cell lung cancer (NSCLC): A Galician Lung Cancer Group phase II study
    Leon, L.
    Vazquez, S.
    Gracia, J. M.
    Lazaro, M.
    Firvida, J. L.
    Casal, J.
    Amenedo, M.
    Santome, L.
    Gallego, R.
    Anido, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] BIWEEKLY DOCETAXEL-CISPLATIN IN CHEMO-NAIVE PATIENTS WITH ADVANCED SQUAMOUS CARCINOMA OF THE LUNG: A GALICIAN LUNG CANCER GROUP PHASE II STUDY
    Lazaro, Martin
    Vazquez, S.
    Jose Villanueva, Maria
    Firvida, J. L.
    Amenedo, Margarita
    Afonso, Javier
    Senin, Clara
    Campos, Begona
    Huidobro, Gerardo
    Areses, Carmen
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1278 - S1279
  • [6] First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naive patients
    Leon, Luis
    Vazquez, Sergio
    Manuel Gracia, Jose
    Casal, Joaquin
    Lazaro, Martin
    Luis Firvida, Jose
    Amenedo, Margarita
    Santome, Lucia
    Macia, Sonia
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1389 - 1396
  • [7] BEVACIZUMAB (B), CISPLATIN (C) AND PEMETREXED (P) PLUS MAINTENANCE B IN CHEMO-NAiVE PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): A PHASE II STUDY
    Lopez Vivanco, G.
    Carrera Revilla, S.
    Sancho Gutierrez, A.
    Marrodan Ciordia, I.
    Azkona Uribelarrea, E.
    Iruarrizaga Ovejas, E.
    Rubio Etxebarria, I.
    Cardona, J. V.
    Munoz Llerena, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S72 - S72
  • [8] A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
    Chen, Yuh-Min
    Perng, Reury-Perng
    Shih, Jen-Fu
    Whang-Peng, Jacqueline
    LUNG CANCER, 2008, 61 (02) : 214 - 219
  • [9] A phase II study of docetaxel plus irinotecan (DOCIRI) in chemo-naive patients with non small cell lung cancer (NSCLC).
    Ziotopoulos, P
    Chandrinos, V
    Samaras, N
    Mylonaki, E
    Stergiou, J
    Zachariadis, E
    Tsiafaki, X
    Agelidou, A
    Ketepozidis, N
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 682S - 682S
  • [10] A phase II randomized trial of vinorelbine plus cisplatin or docetaxel plus cisplatin in inoperable, chemo-naive non-small cell lung cancer patients
    Chen, Y
    Shih, J
    Tsai, C
    Perng, R
    Whang-Peng, J
    LUNG CANCER, 2005, 49 : S389 - S389
12345